Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 138 of the 140 references it cites were found in a registry or an index.

Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy?

Open access

Abstract

Tumor immune microenvironment (TIME), a tumor-derived immune component, is proven to be closely related to the development, metastasis, and recurrence of tumors. Gut microbiota and its fermented-metabolites short-chain fatty acids (SCFAs) play a critical role in maintaining the immune homeostasis of gastrointestinal tumors. Consisting mainly of acetate, propionate, and butyrate, SCFAs can interact with G protein-coupled receptors 43 of T helper 1 cell or restrain histone deacetylases (HDACs) of cytotoxic T lymphocytes to exert immunotherapy effects. Studies have shed light on SCFAs can mediate the differentiation and function of regulatory T cells, as well as cytokine production in TIME. Additionally, SCFAs can alter epigenetic modification of CD8+ T cells by inhibiting HDACs to participate in the immune response process. In gastrointestinal tumors, the abundance of SCFAs and their producing bacteria is significantly reduced. Direct supplementation of dietary fiber and probiotics, or fecal microbiota transplantation to change the structure of gut microbiota can both increase the level of SCFAs and inhibit tumor development. The mechanism by which SCFAs modulate the progression of gastrointestinal tumors has been elucidated in this review, aiming to provide prospects for the development of novel immunotherapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2023.1158200

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The effects of short chain fatty acids on metabolic homeostasis. SCFAs are produced by gut microbiota fermenting soluble dietary fiber in colon. Most SCFAs are absorbed by colonocytes via MCT-1 and SMCT-1, while small part of SCFAs pass directly through the intestinal barrier by passive diffusion. SCFAs transported to various organs of the whole body exert different functions mainly by binding with GPCRs on cells. By coordinating various organs and systems, SCFAs regulate energy balance and maintain metabolic homeostasis. SCFAs, short chain fatty acids; MCT-1, monocarboxylate transporter 1; SMCT-1, sodium-coupled monocarboxylate transporter 1; GLP-1, glucagon-like peptide-1; PYY, peptide tyrosine tyrosine; pAMPK, phosphorylated adenosine monophosphate activated protein kinase; GLUT-4, glucose transporter-4; FA, fatty acids.
Figure 1 The effects of short chain fatty acids on metabolic homeostasis. SCFAs are produced by gut microbiota fermenting soluble dietary fiber in colon. Most SCFAs are absorbed by colonocytes via MCT-1 and SMCT-1, while small part of SCFAs pass directly through the intestinal barrier by passive diffusion. SCFAs transported to various organs of the whole body exert different functions mainly by binding with GPCRs on cells. By coordinating various organs and systems, SCFAs regulate energy balance and maintain metabolic homeostasis. SCFAs, short chain fatty acids; MCT-1, monocarboxylate transporter 1; SMCT-1, sodium-coupled monocarboxylate transporter 1; GLP-1, glucagon-like peptide-1; PYY, peptide tyrosine tyrosine; pAMPK, phosphorylated adenosine monophosphate activated protein kinase; GLUT-4, glucose transporter-4; FA, fatty acids.CC BY · PubMed Central
Figure 2 The effects of short chain fatty acids on tumor immune microenvironment. Depending on activation of STAT3 and mTOR, SCFAs promote Th1 cell expression of Blimp-1, which increases IL-10 expression. Butyrate and pentanoate promote the expression of IL-12 and IL-2 respectively in CD8+ T cells via HDACs inhibitory activity. Acetate decreases the expression of PVR/CD155 through inactivation of PI3K/AKT pathway, thus enhancing the response of CD8+ T cells. SCFAs induce IL-22 production in CD4+ T cells and ILCs, which is mediated by HIF-1α and AhR or involved by Stat3 and mTOR. Butyrate facilitates the anti-PD-1 mAb efficacy via regulating the T cell infiltration, while butyrate reduces efficacy of CTLA-4 blockade and limits DC maturation. Furthermore, SCFAs induce apoptosis of cancer cells through multiple ways. STAT3, signal transducer and activator of transcription 3; mTOR, mammalian target of rapamycin; Blimp-1, B lymphocyte-induced maturation protein 1; PI3K, phosphoinositide 3-kinase; AKT, the protein kinase B; PVR, poliovirus receptor; HRE, hypoxia response element; AhR, aryl hydrocarbon receptor; HIF-1α, hypoxia inducible factor-1α; IL, interleukin; Th, T helper; CTL, cytotoxic T lymphocyte; ILC, innate lymphocyte cell.
Figure 2 The effects of short chain fatty acids on tumor immune microenvironment. Depending on activation of STAT3 and mTOR, SCFAs promote Th1 cell expression of Blimp-1, which increases IL-10 expression. Butyrate and pentanoate promote the expression of IL-12 and IL-2 respectively in CD8+ T cells via HDACs inhibitory activity. Acetate decreases the expression of PVR/CD155 through inactivation of PI3K/AKT pathway, thus enhancing the response of CD8+ T cells. SCFAs induce IL-22 production in CD4+ T cells and ILCs, which is mediated by HIF-1α and AhR or involved by Stat3 and mTOR. Butyrate facilitates the anti-PD-1 mAb efficacy via regulating the T cell infiltration, while butyrate reduces efficacy of CTLA-4 blockade and limits DC maturation. Furthermore, SCFAs induce apoptosis of cancer cells through multiple ways. STAT3, signal transducer and activator of transcription 3; mTOR, mammalian target of rapamycin; Blimp-1, B lymphocyte-induced maturation protein 1; PI3K, phosphoinositide 3-kinase; AKT, the protein kinase B; PVR, poliovirus receptor; HRE, hypoxia response element; AhR, aryl hydrocarbon receptor; HIF-1α, hypoxia inducible factor-1α; IL, interleukin; Th, T helper; CTL, cytotoxic T lymphocyte; ILC, innate lymphocyte cell.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 140 references

Research works printed but not linked: 1

  1. Kang, 2023, Butyrate ameliorates colorectal cancer through regulating intestinal microecological disorders, Anticancer Drugs, 34, 10.1097/cad.0000000000001413 · DOI

Cited by

See all 107

Metadata

Authors
Dong, Y., Zhang, K., Wei, J., Ding, Y., Wang, X., Hou, H., Wu, J., Liu, T., Wang, B., & Cao, H.
Affiliations
Tianjin Medical University General Hospital (CN)
Corresponding author
Cao, Hailong
Venue
Frontiers in Immunology
Published
2023-04-14
Volume
14
Pages
1158200-1158200
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4365516124
Cited by
107
References
140
Citations by year
2026: 36 · 2025: 41 · 2024: 25 · 2023: 5
FWCI
2.82
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (82070545, 82100574, 81970477)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
gut microbiota, short-chain fatty acids, gastrointestinal cancer, tumor immune microenvironment, butyrate, histone deacetylase, GPR43, regulatory T cells, CD8+ T cells, epigenetic modifications, dietary fiber, probiotics, fecal microbiota transplantation, immunotherapy
MeSH terms
Gastrointestinal Microbiome, Butyrates, Fatty Acids, Volatile, Gastrointestinal Neoplasms, Humans, CD8-Positive T-Lymphocytes, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy? https://app.cochat.ai/papers/10.3389/fimmu.2023.1158200
The paper
Dong, Y., Zhang, K., Wei, J., Ding, Y., Wang, X., Hou, H., Wu, J., Liu, T., Wang, B., & Cao, H. (2023). Gut microbiota-derived short-chain fatty acids regulate gastrointestinal tumor immunity: a novel therapeutic strategy? Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1158200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.